Litcius/Paper detail

Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial

Clarice S. Groeneveld, Christian Pfister, S. Culine, V. Harter, C. Krucker, Jacqueline Fontugne, V. Dixon, N. Sirab, Isabelle Bernard‐Pierrot, Aurélien de Reyniès, F. Radvanyi, Yves Allory, G. Pignot, J.P. Fendler, Laurent Guy, G. Verhoest, N. Mottet, A. Doerfler, Sophie Abadie‐Lacourtoisie, A.R. Azzouzi, P. Mongiat, Lionnel Geoffrois, P. Eschwege, F. Di Fiore, Guilhem Roubaud, J.L. Hoepffner, P. Barthelemy, H. Lang, Éric Voog, E. Mandron, J.M. Tourani, C. Serrrate, A. Colau, C. Saldana, Alexandre de la Taille, Trang Huyen Thi Nguyen, F. Kleinclauss, Yohann Loriot, Jacques Irani, J.C. Eymard, S. Larré, O. Huillard, Marc Zerbib, Frédéric Rolland, J. Rigaud, N. Houede, S. Droupy, Gabriel G. Malouf, Morgan Rouprêt, S. Vieillot, N. Letang, T. L'Haridon, N. Gaschignard, Werner Hilgers, Jean‐Louis Davin

2024Annals of Oncology28 citationsDOI

Topics & Concepts

MedicineBladder cancerOncologyChemotherapyBasal (medicine)Internal medicineNeoadjuvant therapyCancerBreast cancerInsulinBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesFerroptosis and cancer prognosis